International Diabetes and Degenerative Diseases Conference

Meet the expert advisors and Keynote Speakers

Dr. Nick N Gorgani

President and CEO at GlyConMedics, LLC, USA

Dr. Gorgani, PhD is the inventor of a new treatment for type 2 diabetes mellitus and the founder and CEO of OzStar Therapeutics and GlyConMedics, LLC. He has a multidisciplinary background spanning chemical engineering to medicine to immunology and to industrial drug development. He has worked for academic institutions, hospitals, biotechnology and pharmaceutical companies. He contributed to numerous classes of patentable discoveries including, non-inflammatory disposal of pathogens and dying cells, a new biologic for the treatment of RA and AMD, mechanism of action of a small molecule that mediates immune tolerance and a world first-in-class small molecule to treat proteinuria.

Read more >

Dr. Susan Guzman

Behavioral Diabetes Institute, USA

Susan Guzman, Ph.D. is a clinical psychologist specializing in diabetes. Her clinical focus areas include overcoming barriers to good management, family issues, and promoting attitudes that support living well with diabetes, from diagnosis throughout life. Dr. Guzman integrates empathy, acceptance and practical guidance to help people better utilize their strengths in living life with diabetes. In 2003, Dr. Guzman co-founded the Behavioral Diabetes Institute (BDI), the first non-profit organization devoted to the emotional and behavioral aspects of living with diabetes. At BDI, she has served as the Director of Clinical/Educational Services developing and leading programs for people with diabetes and training for Healthcare Professionals.

Read more >

Dr. Shailini Singh

Director of Metabolic syndrome Center at NYU Langone Medical Center, USA

Dr. Shailini Singh was born and raised in India. After earning her undergraduate degree from Banaras Hindu University and her medical degree from the Medical School at Lady Hardinge Medical College, New Delhi, India, she proceeded to Canada in January 1968 to become an Obstetrician and Gynecologist. She received her FRCS(C) from there and moved to USA in 1975. She became the first Maternal Fetal Medicine fellow at Harvard Medical School and Joslin Diabetes Foundation in 1975. There she had the privilege to work with Dr. Priscilla White, who was the God mother to all pregnant diabetic patients.Dr. Singh did her second fellowship from the University of Colorado. Following which she stayed on for next 10 years as a faculty in the obstetrician / gynecology department at the University. In 1993-1994 she was a senior Fulbright Scholar to AIIMS, New Delhi India. During her tenure as a Fulbright Scholar she taught around the country as well as conducted research on the effects of Chronic Maternal Anemia on fetus at AIIMS, and Safdarjang Hospital, New Delhi.Currently she is a director of Metabolic syndrome Center at NYU Langone Medical Center, USA. She also had some training in invasive prenatal diagnosis from University of Puericulture in Paris, France and also worked at King Faisal Medical Center in Riyadh, Saudi Arabia through Yale Medical School Saudi- US project.

Read more >

Dr. John G. Geisler

Founder & Chief Scientific Officer at Mitochon Pharmaceuticals, USA

John G. Geisler, Ph.D.,Founder & Chief Scientific Officer,Mitochon Pharmaceuticals, Inc.– Expertise in drug discovery in metabolic disease (Pfizer, Ionis, JnJ) with a primary role bringing forward the inception of new ideas. By striving to working at the root of problems and years of attempting to partition lipids to restore insulin sensitivity, Dr. Geisler has built an expertise in mitochondrial energy expenditure. From this work, stemmed a broader understanding of new mitochondrial targeted applications, and significant gaps of pharmacological interventions for insidious movement disorders and neurodegenerative diseases. Dr. Geisler holds a Ph.D. in Mammalian Genetics from University of Tennessee, conducted at Oak Ridge National Laboratories (ORNL), and a fellowship at Yale University, focused on the physiology and whole-body flux. Mitochon Pharmaceuticals was launched Nov 2014 along with co-founder, Robert Alonso and is now clinically staged.

Read more >


The Diabetes 2017 hosted and organized by Clyto Access from 18th September 2017 in San Diego State University, San Diego, USA with the theme of "Enhanced studies on Diabetes and Degenerative diseases". Diabetes 2017 will address the key challenges of the field by leading experts engaged in diabetic and other degenerative diseases research and takes a unique opportunity to share ideas about significant advances, treatment and bring about life changing solutions for the people suffering from diabetes and other degenerative diseases.

Diabetes 2017 will help to raise awareness about the importance of diabetes as a global public health problem. Therefore, the Diabetes 2017 intends to instigate awareness in terms of control and prevention of Diabetes and its complications. Owing to the prevalence of the Diabetes complications, the major focus of the Diabetes conference is to bring in innovative approaches and the ideas to combat the serious issues affecting the qualities of life due to Diabetes and degenerative diseases (Alzheimer's disease, Cancer, Friedreich's ataxia, Huntington's disease, Chronic traumatic encephalopathy, Atherosclerosis etc.)

Points to discuss

☛ to exchange views on novel diagnostic and therapeutic tools for Diabetes Mellitus and metabolic diseases
☛ to discuss recent advances in molecular biomarkers for Diabetes Mellitus and Degenerative Diseases
☛ to share views on recent progress in Neurodegenerative diseases and Alzheimer's Disease   Research
☛ to discuss highlights in combined immunotherapy with “anti-insulin resistance".
☛ to discuss recent therapeutic strategies for replacement and preservation in retinal degenerative diseases.

diabetes@clytoaccess.com

Related Topics

Diabetes Type 1, Diabetes Type 2, Gestational diabetes, Artificial or Bionic pancreas, Novel routes of insulin administration, Osteoporosis, Islet Cell Transplantation, Kidney replacement therapy, Neuropathy, Nephropathy, Alzheimer's disease, Diabetic Ketoacidosis, Diabetes and Obesity, Glucose Clamp Techniques, Tissue Biopsies in Diabetes Research, Anti-insulin resistance, Glycemic biomarkers, Degenerative diseases, Hypoglycemia, Hyperglycemia, Diabetes Drugs in Development, Diabetes diet, Blood glucose, Neurodegenerative disease, Glucometer, Juvenile diabetes, Diabetes and depression, Biomarkers of Neurodegenerative Diseases, Oral Medications for Diabetes, Intensive Insulin Therapy, Telemedicine, Pediatric Diabetes, Diabetic Foot Pain and Ulcers
Abstract submission deadline (1st round)
07 August 2017
Notification of acceptance or rejection of abstract
03-10 working days from the date of submission
Final presentation should be submitted
15 days before the conference date
Early bird registration
30 May 2017

AGENDA

☛ Drug development for Diabetes
☛ Use of telemedicine for diabetes management
☛ Insulin therapy and delivery methods
☛ Artificial or Bionic pancreas
☛ Pancreas and islet transplants and beta cell replacement
☛ Computerised applications in Diabetes and its mitigations
☛ Emerging screening and monitoring technologies of Diabetes
☛ Biomarker Discovery for Treatment of Diabetes
☛ Precision Medicine in Diabetes
☛ Diabetic hypoglycemia
☛ Cardiopathy and diabetes
☛ Neuropathy and diabetes
☛ Retinopathy and diabetes
☛ Obesity and diabetes
☛ Foot and wound care - diabetes
☛ Cell and regenerative medicine for Diabetes
☛ Impact of lifestyle on development of diabetes
☛ Market Analysis of Diabetic Products
☛ Endocrinology and Diabetes
☛ Bone and joint problems associated with diabetes
☛ Diabetes and Hypertension
☛ Diabetes and Cancer
☛ Hypertension in pregnancy: Diagnosis and management
☛ Gestational Diabetes Causes, Diagnosis, and Treatment
☛ Pediatric Endocrinology and Diabetes
☛ Type 2 diabetes associated with brain degeneration
☛ Cognitive impairment and Alzheimer's disease in type 2 diabetes

What is Diabetes Conference 2017?

Diabetes is one of the major public health concerns that occur either due to lack of insulin production in the islets cells of the pancreas or due to ineffective use of insulin in the body. According to a WHO, as of 2016, an estimated 422 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. A degenerative disease is a type of a medical condition that causes a tissue or organ to deteriorate over time. There are quite a number of degenerative diseases and many of them are associated with aging or get worse during the aging process.

Who to attend Diabetes conference 2017?

Diabetes 2017 is providing a platform for professionals like physicians, researchers, nurses, dietitians, podiatrists, pharmacists, psychologists, endocrinologists, scientists, residents, research fellows, diabetes societies & associations, pharmaceutical companies, faculty/students from universities/institutes.

Why to attend Diabetes Conference 2017?

• Explore new research treatment and management options which can be implemented
• Evaluate the latest insulin and pump therapy treatments
• Evaluate current medical advances and technologies in diabetes and other degenerative diseases
• Listen to best-renowned speakers via Keynote presentations, giving delegates the opportunity to hear the latest research or innovation in diabetes and other degenerative diseases
• Network and share innovative ideas and practices designed to improve the care for patients

MARKET ANALYSIS

The global diabetes market is valued at $125 billion in 2016. This market is expected to grow at a compound annual growth rate (CAGR) of 4.4% to reach $155 billion in 2021. The oral hypoglycemic drugs market reached $67 billion in 2016 and is expected to grow at a compound annual growth rate (CAGR) of 5.6% to reach $88 billion in 2021. The monitoring devices and accessories market reached $11 billion in 2016 and is expected to grow at a compound annual growth rate (CAGR) of 9.1% to reach $17 billion in 2021.
Diabetes conference, clyto access

CONFERENCE HIGHLIGHTS

The panel discussion will provide you an opportunity to share the views on current challenges and the future scopes of the services related to Diabetes Mellitus and Degenerative Diseases. The main discussions will primarily focus on the speech sessions such as Artificial or Bionic Pancreas, Novel routes of Insulin administration, Islet Cell Transplantation, Kidney Replacement Therapy, Neuropathy, Nephropathy, Alzheimer's disease, Diabetic Ketoacidosis, Diabetes and Obesity, Glucose Clamp Techniques, Tissue Biopsies in Diabetes Research, Glycemic biomarkers, Urinary Biomarkers of Brain Diseases, Degenerative disease, Atherosclerosis, Prognostic Biomarkers, Hypoglycemia, Hyperglycemia, Neuroimaging Biomarkers of Neurodegenerative Diseases, Oral Medications for Diabetes, Assessment of Insulin Sensitivity, Intensive Insulin Therapy, Drug Development opportunities in Diabetes, Computerized case management/telemedicine, Pediatric Diabetes
Keynote speakers and speakers would share their expertise and their current research work. The students (Ph.D. and Post Doc. Fellows) can present their posters.
The keynote speakers and the speakers from all over the globe will present their valuable work and share their experiences. The presentations will be nominated for “Best young researcher” award. The industry experts chairing the sessions will decide the awardee based upon the certain criterion. The students involved in the research can present their posters. The best poster will be awarded “Best Poster “award. The scientific program will give you brief details of the presentations invited for speech. All of our presentation sessions are versatile and covering most of the key areas of the field.
Industry professionals and academic professionals delivering a workshop on various methods and techniques, with interactive Q&A session.
Providing counseling and career guidance with Industry experts.

Organizing Committee

Our Speakers

Poster Presentation

Event Schedules

Programs Programs Detail Time
1

SPOT REGISTRATIONS 08:15 - 08:45
2

Opening Ceremony: Inauguration of Diabetes Conference - 2017 08:45- 09:00
3

KEYNOTE SESSIONS #1

TITLE: Metabolic Syndrome (MS): Perils of pregnancy and precursor of childhood obesity and future development of MS
AUTHOR: Dr. Shailini Singh, NYU Langone Medical Center, USA
09:00 - 09:25
4

KEYNOTE SESSIONS #2

TITLE: The Uses of Mitochondrial Specific Protonophore,MP101, as a Broad Spectrum Agent for Neuromuscular and Neurodegenerative Disorders.
AUTHOR: Dr. John G. Geisler, Mitochon Pharmaceuticals, USA
09:25 - 09:50
5

KEYNOTE SESSIONS #3

TITLE: Treatment of type 2 diabetes
AUTHOR: Dr. Nick Gorgani, GlyConMedics, LLC, USA
09:50 - 10:15
6

Hall - Fowler Family Ballroom

Group Photo, Networking and Refreshment Break 10:15-10:50
7

KEYNOTE SESSIONS #4

TITLE: Exosome biomarkers derived from pregnant urine samples can be used to assess the effects of diabetes during pregnancy
AUTHOR: Prof. Satish P. Ramachandra Rao, Exosome Research Center, India
10:50 - 11:15
8

KEYNOTE SESSIONS #5

TITLE: Changing the Conversation in Diabetes: From Discouraged to Engaged.
AUTHOR: Dr. Susan Guzman, Behavioral Diabetes Institute, USA
11:15 - 11:40
9

SPEAKER SESSIONS# 1

TITLE: Smart Supplements and Blood Glucose in Bariatric Patients: A Retrospective Analysis
AUTHOR: Dr. Reza Malek, Vitagene, USA
11:40 - 12:00
10

SPEAKER SESSIONS# 2

TITLE: Restoration of Metabolic Rhythms Attenuates Diabetes and Obesity-Induced Cardiometabolic Disorders.
AUTHOR: Dr. Girish C. Melkani, San Diego State University, USA
12:00 - 12:20
11

SPEAKER SESSIONS# 3

TITLE: Challenges in Diabetes and Clinical Trials: A Xpedited Solution.
AUTHOR: Dr. Vineeta Sharma, Xpedite Pharma Solutions, USA
12:20 - 12:40
12

Lunch Break 12:40 - 13:40
13

SPEAKER SESSIONS# 4

TITLE: Reversing the Effects of Type 2 Diabetes Through Individualized Holistic Lifestyle Changes Versus Conventional Treatment Process.
AUTHOR: Denise A. Pancyrz, Diabetes Reversal Coach, USA
13:40 - 14:00
14

SPEAKER SESSIONS# 5

TITLE: Healing of A Diabetic Foot Ulcer Without Drugs – A Case Study.
AUTHOR: Dr. Mulleri Koroth Amritha, Janatha Hospital,Vadakara,Kerala, India
14:00 - 14:20
15

SPEAKER SESSIONS# 6

TITLE: Nailfold capillaroscopy in Diabetes Mellitus.
AUTHOR: Dr. Genessis Maldonado, Universidad de Especialidades Espíritu Santo (UEES), Ecuador
14:20 - 14:40
16

SPEAKER SESSIONS# 7

TITLE: Role of Ademolus Classification of Hypoglycemia (ACH) in Blood Glucose and Diabetes Mellitus Management.
AUTHOR: Dr. Adegbenga B. Ademolu, National Postgraduate Medical College of Nigeria, Nigeria
14:40 - 15:00
17

Poster Presentation

TITLE: Self Care Practice And Its Associated Factors Among Diabetic Patients In Addisababa Public Hospitals, Cross Sectional Study.
AUTHOR: Melat Mamo Biadglegn, Project officer, Ethiopia
15:00 - 15:15
18

Group Photo, Networking and Refreshment Break 15:15-15:45
19

SPEAKER SESSIONS# 8

TITLE: Digital technology and genetics-based dietary recommendations for prevention and treatment of type 2 diabetes
AUTHOR: Christina Troutner, Nutrition for Longevity, USA
15:45 - 16:05
20

SPEAKER SESSIONS# 9

TITLE: Hypoglycemic effect of methanolic extract of Anacardiumoccidentaleleaves in alloxan-induced diabetic rats
AUTHOR: Temitope Richard Fagbohun, University of the Witwatersrand, South Africa
16:05 - 16:25
21

Certificate distribution| Networking

End of the Day 16:25 - 17:00

Video Presentation

venue

San Diego, USA

address

San Diego State University
500 Campanile Dr, San Diego, CA 92182
Public university in San Diego, California